MARKETS
Earnings

Q32 Bio Q2 EPS $(0.44) Beats $(0.54) Estimate

Aug 5, 2026 · 07:21 AM ET· updated 2h ago

Q32 Bio (NASDAQ:QTTB) reported quarterly losses of $(0.44) per share which beat the analyst consensus estimate of $(0.54) by 18.52 percent. This is a 43.59 percent increase over losses of $(0.78) per share from the same

Share
Why It Matters

Q32 Bio lost less money than people expected this quarter, which is good news. When a company that's still losing money does better than predicted, it shows they're getting closer to being healthier.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.